Cargando…
Peptide mimics selected from immune sera using phage display technology can replace native antigens in the diagnosis of Epstein–Barr virus infection
There is an expanding area of small molecule discovery, especially in the area of peptide mimetics. Peptide sequences can be used to substitute for the entire native antigen for use in diagnostic assays. Our approach is to select peptides that mimic epitopes of the natural immune response to Epstein...
Autores principales: | Casey, J.L., Coley, A.M., Parisi, K., Foley, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660343/ https://www.ncbi.nlm.nih.gov/pubmed/19073711 http://dx.doi.org/10.1093/protein/gzn076 |
Ejemplares similares
-
Epstein Barr Virus and Mycobacterium avium subsp. paratuberculosis peptides are recognized in sera and cerebrospinal fluid of MS patients
por: Mameli, Giuseppe, et al.
Publicado: (2016) -
A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus
por: Zhong, Ling, et al.
Publicado: (2022) -
Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
por: Smith, Danielle Westhoff, et al.
Publicado: (2013) -
Generation and Characterization of a Novel Recombinant Antibody against LMP1-TES1 of Epstein-Barr Virus Isolated by Phage Display
por: Zhang, Dawei, et al.
Publicado: (2013) -
Perspectives of Phage–Eukaryotic Cell Interactions to Control Epstein–Barr Virus Infections
por: Górski, Andrzej, et al.
Publicado: (2018)